High-Potency Cannabis: America’s New Pastime and Psychiatry’s Next Challenge
High-potency cannabis psychiatric risks are increasingly relevant as these products are marketed for mental health conditions despite limited evidence. Clinicians must understand these risks to guide patients effectively. This article highlights the…
Behavioral Science in Clinical Trials: Part 3 — Why Diversity Must Be Built Into Trial Design
Behavioral science clinical trials diversity is essential for ensuring cannabis research reflects real-world populations. Poor diversity limits generalizability and may overlook key differences in efficacy and safety. Integrating behavioral science…
Safety of Cannabidiol in Healthy Adults: A Meta-Analysis Review
This systematic review examines cbd safety in healthy adults, comparing cannabidiol to placebo. The meta-analysis highlights key adverse effects observed in non-patient populations. Understanding cbd safety in healthy adults is crucial for informed…
India to Start Human Trials for Medicinal Cannabis
India medicinal cannabis trials mark a pivotal shift in drug policy and research. These human trials aim to produce controlled safety and efficacy data. This research could accelerate medicinal cannabis acceptance across South and Southeast Asia.
Op-Ed: The Essential Role of Pharmacists in Cannabis Care
Pharmacists cannabis care role is crucial for patient safety in cannabis therapy. Their involvement ensures professional drug interaction checks and standardized dosing advice. Integrating pharmacists into cannabis care fills a critical gap in medication…
5 Exciting Insights from the MedCan 3 Trial
MedCan 3: A Landmark Study on Medicinal Cannabis for Cancer Symptom Management More access here The MedCan 3 study is a highly anticipated clinical trial investigating the potential of medicinal cannabis to alleviate symptoms in patients…